Exactly my thinking, apart from doing the odd local Biotech showcase, which they have already done, and interviews when announcements are released, which Michael always does and more so than other CEO’s.
I’d rather him be focused on running the company and bringing us closer to a positive Ph2 result via HEALY than creating announcements for the sake of it.
When there is something worthwhile to announce, we will see it.
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$, page-305
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $80.25M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.3¢ | $89.46K | 536.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 287162 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 17500 | 1 |
View Market Depth
| Last trade - 13.45pm 17/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |